Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis
OWL Genomics, biotechnological company, has presented at the CIC bioGUNE hold at the Bizkaia Technological Park (Derio), the first DNA chip concerning diagnosis and prognosis of non-alcoholic steatohepatitis (NASH), allowing the discrimination between normal, steatosis and NASH predisposed subjects....... Non alcoholic steatohepatitis is a progressive disease of the liver of unknown etiology, cha...